Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3015 SEK | +3.97% | -52.22% | -96.98% |
Mar. 18 | Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index | CI |
Feb. 26 | Transcript : Xbrane Biopharma AB, 2023 Earnings Call, Feb 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-96.98% | 814K | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |
- Stock
- Equities
- Stock Xbrane Biopharma AB - Nasdaq Stockholm
- News Xbrane Biopharma AB
- EU Clears Xbrane-STADA's Biosimilar of Novartis' Eye Drug Lucentis